Importantly, PAX7 target gene score repression progresses in FSHD patient muscle over a year, a unique feature not achieved by DUX4, DUX4 target gene expression or non‐transcriptomic markers (Banerji, 2020). Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.